Viewing Study NCT05155800


Ignite Creation Date: 2025-12-26 @ 12:17 PM
Ignite Modification Date: 2025-12-31 @ 12:45 PM
Study NCT ID: NCT05155800
Status: COMPLETED
Last Update Posted: 2023-11-22
First Post: 2021-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury
Sponsor: Sense Diagnostics, LLC
Organization:

Study Overview

Official Title: A Prospective, Non-Randomized, Sequentially Enrolled, Multi-Center, Phase II Study to Evaluate the SENSE Device's Ability to Detect and Monitor Traumatic Brain Injury
Status: COMPLETED
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Sense-005
Brief Summary: The study population will consist of 3 mutually-exclusive sets of patients and subjects:

* TBI patients with intracranial bleeding
* TBI patients without intracranial bleeding
* Control subjects with normal brain health.

Research subjects between the ages of 22 to 50 will be enrolled. All TBI patients must have a diagnostic head CT scan within 24 hours of the injury. TBI patients without intracranial bleeding based on the CT scan must have a Glasgow Coma Scale (GCS) score at enrollment of ≤ 14. Total maximum duration of active monitoring with the device in this study is 48 hours with a clinical follow-up at day 7 after enrollment.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: